TAKEDA PHARMACEUTICAL CO LTD
CIK
1395064
Location
Tokyo, M0
Portfolio Value
Micro
$31,644,139
Diversification
Highly concentrated
Filing Date
Global Rank
#7,002
/ 7,986
▲ 298
· as of Sep 2025
Top Industry
Biotechnology
98.4%
3Y Alpha vs SPY
-2.5%
Period ended 9 months ago
Filed Nov 13, 2025 · 8mo
8 quarters · since Dec 2023
Clone Performance
Feb 2024–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+49.7%
SPY
+53.6%
Annualised alpha
-1.3%
Max drawdown
−57.4%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
7 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025Top Position
55.0%
−21.6 pts
Top 5
99.6%
+0.3 pts
Top 10
100.0%
0.0 pts
HHI
4,070
Highly concentrated−2,009
Portfolio Trend
8 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $31,644,139 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
7 positions ·
$31,644,139 total
· as of Sep 30, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| XLO |
Xilio Therapeutics, Inc.
Healthcare
|
Held | 1,475,121 | $17,409,378 | 55.02% | |
| OVID |
Ovid Therapeutics Inc.
Healthcare
|
Held | 7,531,996 | $9,791,594 | 30.94% | |
| EQ |
Equillium, Inc.
Healthcare
|
Held | 1,824,977 | $2,609,717 | 8.25% | |
| STTK |
Shattuck Labs, Inc.
Healthcare
|
Held | 515,619 | $1,232,329 | 3.89% | |
| AMWL |
American Well Corp
Healthcare
|
Held | 77,733 | $478,057 | 1.51% | |
| RANI |
Rani Therapeutics Holdings, Inc.
Healthcare
|
Held | 203,190 | $101,595 | 0.32% | |
| LAB |
Standard Biotools Inc.
Healthcare
|
Held | 16,515 | $21,469 | 0.07% |